# Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

> **NCT06720207** · — · NOT_YET_RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Non Hodgkin's Lymphoma
- Multiple Myeloma (MM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06720207
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06720207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06720207, "Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06720207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*